Patienter med leverdysfunktion inkl. kronisk aktiv hepatitis har en øget forekomst af leverfunktionsabnormiteter ved kombinationsbehandling og bør monitoreres iht almindelig praksis.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination therapy and should be monitored according to standard practice.